[96a5a0]: / output / allTrials / identified / NCT03546972_identified.json

Download this file

554 lines (554 with data), 24.3 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
{
"info": {
"nct_id": "NCT03546972",
"official_title": "Choosing Health and Cancer Risk Reduction Through Good Eating and Exercise",
"inclusion_criteria": "* Body Mass Index (BMI) >= 27 kg/m^2.\n* At high risk of developing breast cancer defined by one or more of the following: Gail model lifetime risk > 20% or a 5 year risk >1.66%, a history of deleterious BRCA1/2 mutation or mantle radiation, a history of ductal cancer in situ, or a history of high risk premalignant breast lesion.\n* 12 months without a period/menstrual cycle or having had a bilateral oophorectomy.\n* Ability to take digital time stamped photos.\n* Internet access (daily).\n* Reports being proficient in English (can read/write and speak fluently).\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 30 Years\nMust have maximum age of 70 Years",
"exclusion_criteria": "* Previous participation in this trial. Participation is defined as screening. Re-screening is not allowed except for individuals excluded for BMI. Patients previous screened as ineligible due to BMI are allowed to be re-screened and enrolled if eligible.\n* Has a current measured BMI less than 27 kg/m^2.\n* Reports being unwilling to use Continuous Glucose Monitor (CGM), which requires daily blood sampling by finger pricks.\n* Currently being actively treated for cancer other than nonmelanoma skin cancer.\n* Known inability to participate in the ongoing appointments for the four months of the study and scheduled follow-up tests.\n* Reported current diagnosis or history of type I diabetes or type 2 diabetes.\n* Reported use of oral antidiabetic agents (OADs).\n* Current use of any drug (except metformin) or anticipated change in concomitant medication, which the investigator's opinion could interfere with the glucose metabolism (e.g. systemic corticosteroids).\n* Previous or current treatment with any insulin regimen other than basal insulin, e.g. prandial or pre-mixed insulin (short term treatment due to intercurrent illness including gestational is allowed at the discretion for the investigator).\n* Previous or current treatment with GLP-1 receptor agonists (e.g. exenatide, liraglutide).\n* Fasting blood glucose level > 126 and glycosylated hemoglobin (HbA1c) > 7%.\n* Subjects considered by the investigator as unsuitable for the study for reasons not otherwise stated.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Body Mass Index (BMI) >= 27 kg/m^2.",
"criterions": [
{
"exact_snippets": "Body Mass Index (BMI) >= 27 kg/m^2",
"criterion": "Body Mass Index (BMI)",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": ">=",
"value": 27,
"unit": "kg/m^2"
}
}
]
}
]
},
{
"line": "* At high risk of developing breast cancer defined by one or more of the following: Gail model lifetime risk > 20% or a 5 year risk >1.66%, a history of deleterious BRCA1/2 mutation or mantle radiation, a history of ductal cancer in situ, or a history of high risk premalignant breast lesion.",
"criterions": [
{
"exact_snippets": "Gail model lifetime risk > 20%",
"criterion": "Gail model lifetime risk",
"requirements": [
{
"requirement_type": "risk",
"expected_value": {
"operator": ">",
"value": 20,
"unit": "%"
}
}
]
},
{
"exact_snippets": "5 year risk >1.66%",
"criterion": "5 year risk",
"requirements": [
{
"requirement_type": "risk",
"expected_value": {
"operator": ">",
"value": 1.66,
"unit": "%"
}
}
]
},
{
"exact_snippets": "history of deleterious BRCA1/2 mutation",
"criterion": "deleterious BRCA1/2 mutation",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
},
{
"exact_snippets": "history of ... mantle radiation",
"criterion": "mantle radiation",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
},
{
"exact_snippets": "history of ductal cancer in situ",
"criterion": "ductal cancer in situ",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
},
{
"exact_snippets": "history of high risk premalignant breast lesion",
"criterion": "high risk premalignant breast lesion",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
},
{
"line": "* 12 months without a period/menstrual cycle or having had a bilateral oophorectomy.",
"criterions": [
{
"exact_snippets": "12 months without a period/menstrual cycle",
"criterion": "menstrual cycle",
"requirements": [
{
"requirement_type": "absence_duration",
"expected_value": {
"operator": ">=",
"value": 12,
"unit": "months"
}
}
]
},
{
"exact_snippets": "having had a bilateral oophorectomy",
"criterion": "bilateral oophorectomy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Ability to take digital time stamped photos.",
"criterions": [
{
"exact_snippets": "Ability to take digital time stamped photos.",
"criterion": "ability to take digital time stamped photos",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Internet access (daily).",
"criterions": [
{
"exact_snippets": "Internet access (daily)",
"criterion": "internet access",
"requirements": [
{
"requirement_type": "frequency",
"expected_value": "daily"
}
]
}
]
},
{
"line": "* Reports being proficient in English (can read/write and speak fluently).",
"criterions": [
{
"exact_snippets": "proficient in English (can read/write and speak fluently)",
"criterion": "English proficiency",
"requirements": [
{
"requirement_type": "proficiency",
"expected_value": "proficient"
},
{
"requirement_type": "skills",
"expected_value": [
"read",
"write",
"speak"
]
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be FEMALE",
"criterions": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "female"
}
]
}
]
},
{
"line": "Must have minimum age of 30 Years",
"criterions": [
{
"exact_snippets": "minimum age of 30 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 30,
"unit": "Years"
}
}
]
}
]
},
{
"line": "Must have maximum age of 70 Years",
"criterions": [
{
"exact_snippets": "maximum age of 70 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 70,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Previous participation in this trial. Participation is defined as screening. Re-screening is not allowed except for individuals excluded for BMI. Patients previous screened as ineligible due to BMI are allowed to be re-screened and enrolled if eligible.",
"criterions": [
{
"exact_snippets": "Previous participation in this trial",
"criterion": "previous participation in this trial",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "Re-screening is not allowed except for individuals excluded for BMI",
"criterion": "re-screening",
"requirements": [
{
"requirement_type": "allowance",
"expected_value": false
}
]
},
{
"exact_snippets": "Patients previous screened as ineligible due to BMI are allowed to be re-screened",
"criterion": "BMI exclusion",
"requirements": [
{
"requirement_type": "allowance",
"expected_value": true
}
]
}
]
},
{
"line": "* Has a current measured BMI less than 27 kg/m^2.",
"criterions": [
{
"exact_snippets": "current measured BMI less than 27 kg/m^2",
"criterion": "BMI",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": "<",
"value": 27,
"unit": "kg/m^2"
}
}
]
}
]
},
{
"line": "* Reports being unwilling to use Continuous Glucose Monitor (CGM), which requires daily blood sampling by finger pricks.",
"criterions": [
{
"exact_snippets": "unwilling to use Continuous Glucose Monitor (CGM)",
"criterion": "willingness to use Continuous Glucose Monitor (CGM)",
"requirements": [
{
"requirement_type": "willingness",
"expected_value": true
}
]
},
{
"exact_snippets": "requires daily blood sampling by finger pricks",
"criterion": "ability to perform daily blood sampling by finger pricks",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
}
]
},
{
"line": "* Currently being actively treated for cancer other than nonmelanoma skin cancer.",
"criterions": [
{
"exact_snippets": "Currently being actively treated for cancer",
"criterion": "active cancer treatment",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "cancer other than nonmelanoma skin cancer",
"criterion": "cancer type",
"requirements": [
{
"requirement_type": "exclusion",
"expected_value": "nonmelanoma skin cancer"
}
]
}
]
},
{
"line": "* Known inability to participate in the ongoing appointments for the four months of the study and scheduled follow-up tests.",
"criterions": [
{
"exact_snippets": "Known inability to participate in the ongoing appointments for the four months of the study and scheduled follow-up tests.",
"criterion": "ability to participate in ongoing appointments",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
}
]
},
{
"line": "* Reported current diagnosis or history of type I diabetes or type 2 diabetes.",
"criterions": [
{
"exact_snippets": "Reported current diagnosis or history of type I diabetes",
"criterion": "type I diabetes",
"requirements": [
{
"requirement_type": "diagnosis",
"expected_value": true
}
]
},
{
"exact_snippets": "Reported current diagnosis or history of ... type 2 diabetes",
"criterion": "type 2 diabetes",
"requirements": [
{
"requirement_type": "diagnosis",
"expected_value": true
}
]
}
]
},
{
"line": "* Reported use of oral antidiabetic agents (OADs).",
"criterions": [
{
"exact_snippets": "Reported use of oral antidiabetic agents (OADs)",
"criterion": "oral antidiabetic agents (OADs)",
"requirements": [
{
"requirement_type": "use",
"expected_value": true
}
]
}
]
},
{
"line": "* Current use of any drug (except metformin) or anticipated change in concomitant medication, which the investigator's opinion could interfere with the glucose metabolism (e.g. systemic corticosteroids).",
"criterions": [
{
"exact_snippets": "Current use of any drug (except metformin)",
"criterion": "current drug use",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "anticipated change in concomitant medication",
"criterion": "anticipated change in concomitant medication",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "interfere with the glucose metabolism",
"criterion": "interference with glucose metabolism",
"requirements": [
{
"requirement_type": "potential",
"expected_value": true
}
]
}
]
},
{
"line": "* Previous or current treatment with any insulin regimen other than basal insulin, e.g. prandial or pre-mixed insulin (short term treatment due to intercurrent illness including gestational is allowed at the discretion for the investigator).",
"criterions": [
{
"exact_snippets": "Previous or current treatment with any insulin regimen other than basal insulin",
"criterion": "insulin regimen",
"requirements": [
{
"requirement_type": "type",
"expected_value": "basal insulin"
}
]
},
{
"exact_snippets": "short term treatment due to intercurrent illness including gestational is allowed at the discretion for the investigator",
"criterion": "short term treatment due to intercurrent illness",
"requirements": [
{
"requirement_type": "allowance",
"expected_value": true
}
]
}
]
},
{
"line": "* Previous or current treatment with GLP-1 receptor agonists (e.g. exenatide, liraglutide).",
"criterions": [
{
"exact_snippets": "Previous or current treatment with GLP-1 receptor agonists",
"criterion": "treatment with GLP-1 receptor agonists",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "exenatide, liraglutide",
"criterion": "specific GLP-1 receptor agonists",
"requirements": [
{
"requirement_type": "examples",
"expected_value": [
"exenatide",
"liraglutide"
]
}
]
}
]
},
{
"line": "* Fasting blood glucose level > 126 and glycosylated hemoglobin (HbA1c) > 7%.",
"criterions": [
{
"exact_snippets": "Fasting blood glucose level > 126",
"criterion": "fasting blood glucose level",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": ">",
"value": 126,
"unit": "mg/dL"
}
}
]
},
{
"exact_snippets": "glycosylated hemoglobin (HbA1c) > 7%",
"criterion": "glycosylated hemoglobin (HbA1c)",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": ">",
"value": 7,
"unit": "%"
}
}
]
}
]
},
{
"line": "* Subjects considered by the investigator as unsuitable for the study for reasons not otherwise stated.",
"criterions": [
{
"exact_snippets": "Subjects considered by the investigator as unsuitable for the study for reasons not otherwise stated.",
"criterion": "suitability for the study",
"requirements": [
{
"requirement_type": "investigator's assessment",
"expected_value": "unsuitable"
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}